Director of Computational Biology
Tempus AI
David Jenkins, Ph.D., is Director of Computational Biology, Pharma R&D at Tempus AI in Boston, MA. In this role, he leads a team of computational biologists that supports collaborations with pharmaceutical partners by providing analytical insights from the Tempus dataset.
Prior to joining Tempus, Dr. Jenkins was at AstraZeneca, where he most recently served as the Associate Director of Bioinformatics in Hematology Translational Medicine. There, he supported a portfolio of clinical-stage drug projects by analyzing multimodal trial data to develop biomarkers of drug response. He also contributed to improving genomic analysis pipelines by co-developing a deep learning algorithm for purity and ploidy prediction that matches the performance of human curators.
Dr. Jenkins earned his Ph.D. in Bioinformatics from Boston University and his Bachelor of Science in Computational Biology from Brown University. He has co-authored numerous peer-reviewed papers in esteemed journals, including Cancer Discovery, Clinical Cancer Research, Nature Communications, and Genome Medicine. His work focuses on applying advanced computational methods to large-scale genomic and clinical data to advance cancer therapeutics.